← back to search

Frederick Kamanu

Harvard University · US
Area of research
Genetics · Surgery
Research interest
Research interests include Genetic Associations and Epidemiology, Lipoproteins and Cardiovascular Health, Nutrition, Genetics, and Disease, and Genomics and Rare Diseases.
h-index
17
citations
2,790
works
56
NIH funding
primary concept
Medicine
email

Recent publications

Meta-analysis of genome-wide associations and polygenic risk prediction for atrial fibrillation in more than 180,000 cases
Nature Genetics 2025cited by 36position: middledoi
Endothelial cell-related genetic variants identify LDL cholesterol-sensitive individuals who derive greater benefit from aggressive lipid lowering
Nature Medicine 2025cited by 25position: middledoi
Pathogenic Cardiomyopathy-Associated Gene Variants and Prognosis in Atrial Fibrillation
Journal of the American College of Cardiology 2025cited by 4position: middledoi
Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials
Nature Medicine 2024cited by 37position: middledoi
Novel Polygenic Risk Score and Established Clinical Risk Factors for Risk Estimation of Aortic Stenosis
JAMA Cardiology 2024cited by 19position: middledoi
Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants
Nature Genetics 2022cited by 674position: middledoi
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature 2022cited by 588position: middledoi
Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary Prevention
JAMA Cardiology 2022cited by 127position: middledoi
A polygenic risk score predicts atrial fibrillation in cardiovascular disease
European Heart Journal 2022cited by 77position: middledoi
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries
Nature 2022cited by 12position: middledoi
Stroke genetics informs drug discovery and risk prediction across ancestries
Research Square 2022cited by 10position: middledoi
The Genomics of Heart Failure: Design and Rationale of the HERMES Consortium
ESC Heart Failure 2021cited by 22position: middledoi
Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients With Cardiometabolic Disease
Circulation Genomic and Precision Medicine 2021cited by 14position: middledoi
Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients With Cardiometabolic Disease
Circulation 2020cited by 56position: middledoi
Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score
Circulation 2019cited by 212position: middledoi
Identification of Novel Loci Associated With Hip Shape: A Meta-Analysis of Genomewide Association Studies
Journal of Bone and Mineral Research 2018cited by 67position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Marc S. Sabatine · Smart Material (Germany)8 papers (2019–2025)Patrick T. Ellinor · Icahn School of Medicine at Mount Sinai8 papers (2019–2025)Nicholas Marston · Harvard University8 papers (2019–2025)Christian T. Ruff · Brigham and Women's Hospital8 papers (2019–2025)Giorgio Melloni · Harvard University7 papers (2021–2025)Robert P. Giugliano · Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo7 papers (2019–2025)Benjamin M. Scirica · Harvard University5 papers (2021–2025)Marc P. Bonaca · Amsterdam University Medical Centers5 papers (2021–2025)Deepak L. Bhatt · Technische Universität Dresden5 papers (2021–2025)Carolina Roselli · Broad Institute4 papers (2019–2022)Steven A. Lubitz · Boston Foundation3 papers (2019–2022)Itamar Raz · Thrombolysis in Myocardial Infarction Study Group3 papers (2021–2024)Stephen D. Wiviott · Brigham and Women's Hospital3 papers (2024–2025)Philippe Gabríel Steg · Mount Sinai Hospital3 papers (2021–2025)James P. Pirruccello · University of San Francisco3 papers (2022–2025)Eugene Braunwald · Mass General Brigham3 papers (2021–2025)David D. Berg · Harvard University2 papers (2022–2025) · 2 papers (2019–2021)Michelle L. O’Donoghue · Harvard University2 papers (2022–2024) · 2 papers (2022–2024)